![Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma]()
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastomaGurney, J. G.; Bass, J. K.; Onar-Thomas, A.; Huang, J.; Chintagumpala, M.; Bouffet, E.; Hassall, T.; Gururangan, S.; Heath, J. A.; Kellie, S.; Cohn, R.; Fisher, M. J.; Panandiker, A. P.; Merchant, T. E.; Srinivasan, A.; Wetmore, C.; Qaddoumi, I.; Stewart, C. F.; Armstrong, G. T.; Broniscer, A.; Gajjar, A. · Neuro-Oncology · 2014